OverviewChartNewsTraderScreen

L&S Knock-Out Bavarian Nordic AS/  DE000LX4XMD0  /

EUWAX
2024-12-27  8:09:28 AM Chg.-0.090 Bid10:00:20 PM Ask10:00:20 PM Underlying Strike price Expiration date Option type
0.290EUR -23.68% -
Bid Size: -		 -
Ask Size: -		 - 23.671 EUR 2078-12-31 Call
TeleTrader 08-22 Mpox vaccine maker, Bavarian Nordic, jumps 13% after earnings
GlobeNewswire 08-16 Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents
GlobeNewswire 08-13 Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine
GlobeNewswire 08-08 Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vac...
GlobeNewswire 06-26 Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to...
GlobeNewswire 06-17 Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate
GlobeNewswire 05-31 Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Sm...
GlobeNewswire 04-29 Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chiku...
GlobeNewswire 04-02 Bavarian Nordic Announces Commercial Launch of Mpox Vaccine in the U.S.
GlobeNewswire 02-23 Bavarian Nordic’s Chikungunya Vaccine Candidate Granted Accelerated Assessment by European Medicines...
TeleTrader 2022-08-19 EU makes monkeypox vaccine more available
TeleTrader 2022-08-18 WH announces new strategies against monkeypox
TeleTrader 2022-07-30 Spain confirms second monkeypox death
TeleTrader 2022-07-29 Spain confirms Europe's first monkeypox death
TeleTrader 2022-07-25 Monkeypox vaccine approved by EU
TeleTrader 2022-07-22 EMA gives preliminary approval to monkeypox jab
GlobeNewswire 2022-03-21 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...
GlobeNewswire 2022-02-28 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...
GlobeNewswire 2022-02-14 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...
GlobeNewswire 2021-12-06 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...
GlobeNewswire 2021-12-05 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate
GlobeNewswire 2021-09-01 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate
GlobeNewswire 2021-08-23 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...
GlobeNewswire 2021-08-23 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine
GlobeNewswire 2021-08-09 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine